CLINICAL OUTCOMES ASSOCIATED WITH SODIUM ZIRCONIUM CYCLOSILICATE FOR TREATING HYPERKALAEMIA IN PATIENTS RECEIVING HAEMODIALYSIS

被引：0
|
作者：
Ferraro, P. M. [1 ]
Booth, D. [2 ]
Silvanto, J. [2 ]
McEwan, P. [2 ]
Rao, N. [3 ]
机构：
[1] Univ Cattolica Sacro Cuore, Dipartimento Univ Med Chirurg Traslazional, Rome, Italy
[2] Hlth Econ & Outcomes Res Ltd, Cardiff, Wales
[3] AstraZeneca, Cambridge, England
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO35
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [31] Clinical Implications of Sodium Zirconium Cyclosilicate Therapy in Patients with Systolic Heart Failure and Hyperkalemia
    Imamura, Teruhiko
    Oshima, Akira
    Narang, Nikhil
    Kinugawa, Koichiro
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (23)
  • [32] Dose effect analysis of sodium zirconium cyclosilicate in hemodialysis patients
    Spinowitz, Bruce
    McCafferty, Kieran
    Fishbane, Steven
    Fukagawa, Masafumi
    Guzman, Nicolas
    Ford, Martin
    Rastogi, Anjay
    Bhandari, Sunil
    HEMODIALYSIS INTERNATIONAL, 2022, 26 (02) : 274 - 277
  • [33] Hypokalemia Events With Sodium Zirconium Cyclosilicate and Placebo in Hemodialysis Patients
    Fishbane, Steven
    Ford, Martin
    Fukagawa, Masafumi
    McCafferty, Kieran
    Rastogi, Anjay
    Spinowitz, Bruce
    Staroselskiy, Konstantin
    Vishnevskiy, Konstantin
    Lisovskaja, Vera
    Al-Shurbaji, Ayman
    Guzman, Nicolas
    Bhandari, Sunil
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (04): : 908 - 912
  • [34] Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure
    Tardif, Jean-Claude
    Rouleau, Jean
    Chertow, Glenn M.
    Al-Shurbaji, Ayman
    Lisovskaja, Vera
    Gustavson, Stephanie
    Zhao, Yanli
    Bouabdallaoui, Nadia
    Desai, Akshay S.
    Chernyavskiy, Alexander
    Evsina, Maria
    Merkely, Bela
    McMurray, John J. V.
    Pfeffer, Marc A.
    ESC HEART FAILURE, 2023, 10 (02): : 1066 - 1076
  • [35] Efficacy and safety of sodium zirconium cyclosilicate for hyperkalaemia: the randomized, placebo-controlled HARMONIZE-Global study
    Zannad, Faiez
    Hsu, Bang-Gee
    Maeda, Yoshitaka
    Shin, Sug Kyun
    Vishneva, Elena M.
    Rensfeldt, Martin
    Eklund, Stefan
    Zhao, June
    ESC HEART FAILURE, 2020, 7 (01): : 55 - 65
  • [36] Effectiveness of Sodium Zirconium Cyclosilicate in Hemodialysis Patients With Severe Hyperkalemia
    Ford, Martin
    Fishbane, Steven
    Spinowitz, Bruce
    Rastogi, Anjay
    Guzman, Nicolas
    McCafferty, Kieran
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (12): : 3074 - 3078
  • [37] Sodium zirconium cyclosilicate and metabolic acidosis: Potential mechanisms and clinical consequences
    Fernandez-Prado, Raul
    Villalvazo, Priscila
    Avello, Alejandro
    Gonzalez-de-Rivera, Marina
    Aguirre, Michelle
    Carrasco-Munoz, Carlos G.
    Fernandez-Fernandez, Beatriz
    Martin-Cleary, Catalina
    Carriazo, Sol
    Sanchez-Nino, Maria Dolores
    Perez-Gomez, Maria Vanessa
    Ortiz, Alberto
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 158
  • [38] SODIUM ZIRCONIUM CYCLOSILICATE FOR TREATMENT OF HYPERKALAEMIA: ANALYSIS OF PATIENTS ON RENIN-ANGIOTENSIN-ALDOSTERONE INHIBITORS (RAASI) FROM THE PHASE 3 HARMONIZE STUDY
    Zannad, F.
    Rasmussen, H. S.
    Lavin, P. T.
    Singh, B.
    Yang, A.
    Anker, S. D.
    JOURNAL OF HYPERTENSION, 2015, 33 : E450 - E451
  • [39] Impact of Sodium Zirconium Cyclosilicate Therapy on Nutrition Status in Patients with Hyperkalemia
    Imamura, Teruhiko
    Fujioka, Hayato
    Narang, Nikhil
    Kinugawa, Koichiro
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (01)
  • [40] Acute phase efficacy of sodium zirconium cyclosilicate (zs-9) in patients with severe hyperkalaemia: analysis from two phase 3 studies
    Kosiborod, M.
    Peacock, W. F.
    Lerma, E.
    Rasmussen, H. S.
    Lavin, P. T.
    Singh, B.
    Yang, A.
    Packham, D.
    EUROPEAN HEART JOURNAL, 2015, 36 : 667 - 667
12345